Picture of Iterum Therapeutics logo

ITRMF — Iterum Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapValue Trap

What to Watch in the Day Ahead - Friday, October 25

(The Day Ahead is an email and PDF publication that includes the day's major stories and
events, analyses and other features. To receive The Day Ahead, Eikon users can register at
 DAY/US . Thomson One users can register at RT/DAY/US. All times in ET/GMT)
For the U.S. economy, the Commerce Department is expected to report that orders for durable
goods likely fell 1.0% in September, after remaining unchanged in August. Another report will
probably show that the University of Michigan's final reading on the overall index of consumer
sentiment likely came in at 69 in October, compared with a preliminary reading of 68.9. 

Federal Reserve Bank of Boston President Susan Collins will participate in a fireside chat on
the Boston Fed's portfolio of work, supporting the Fed's Congressional mandates, and how various
sectors – private, public, philanthropic, educational, and nonprofit – can collaborate to
enhance economic vitality before the Black Economic Council of Massachusetts Black Expo in
Boston. (1100/1500)

HCA Healthcare will report its third-quarter earnings. Investor focus is expected to be on
demand for healthcare services at the hospital operator, labor costs as well as management
commentary on the impact of the hurricane season on its operations.

Centene Corp is set to report third-quarter results before markets open. Investors and Wall
Street analysts will focus on the health insurer's medical cost ratio - a unit that measures
medical costs - and comments on the annual outlook as the industry grapples with elevated costs.

New York Community Bancorp is expected to report a third-quarter loss, driven by a steep decline
in interest income and increased provisions for credit losses stemming from its significant
exposure to commercial real estate. Investors will closely monitor cost-saving measures and
management's comments regarding further reductions in the lender's CRE loan portfolio.

The U.S. Food and Drug Administration is expected to decide on approval for Iterum Therapeutics'
oral drug to treat a type of urinary tract infection in women.

The Bank of Canada Governor Tiff Macklem will address journalists and answer questions in-person
and virtually at the sidelines of the IMF meeting in Washington. (1430/1830)

Statistics Canada is due to release data on retail sales in the country which likely increased
0.5% in August, after recording a 0.9% rise in July.

 (Compiled by Ankita Yadav in Bengaluru; Editing by Vijay Kishore)
 ((Ankita.Yadav@thomsonreuters.com;))

Recent news on Iterum Therapeutics

See all news